Oral Nadolol for the Treatment of Adults With Mild Asthma
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm previous observations in asthmatics that chronic
nadolol treatment reduces asthmatic airway hyper-responsiveness.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Invion, Inc.
Collaborators:
Baylor College of Medicine Sandler Program for Asthma Research University of Houston